Multisite Validation of a Strategy to Identify Very Low Risk Emergency Department Patients Without Troponin
Patients with no known coronary artery disease, a nonischemic electrocardiogram, and a HEAR score ≤1 had a missed MACE rate <1%. Troponin testing identified additional patients with MACE but did not significantly improve risk stratification accuracy.
Authors
- Simon A. Mahler (ORCID: https://orcid.org/0000-0003-2199-4078)
- Anna C. Snavely (ORCID: https://orcid.org/0000-0001-6916-4255)
- Tara Hashemian
- Michael Supples (ORCID: https://orcid.org/0000-0001-5999-4554)
- Nicklaus P. Ashburn (ORCID: https://orcid.org/0000-0002-3466-8813)
- Akalya Villenthi
Institutions
- Winston-Salem/Forsyth County Schools (US)
- Wake Forest University (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101913
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Roche
- Wake Forest University
- National Foundation of Emergency Medicine
- Emergency Medicine Foundation
- National Institutes of Health
- Health Resources and Services Administration
- Agency for Healthcare Research and Quality
- Abbott Pharmaceuticals
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences
- Wake Forest Clinical and Translational Science Institute, Wake Forest School of Medicine